Twenty patients with good ventricular function undergoing coronary artery bypass surgery were studied to determine whether the pre-bypass use of nitrous oxide resulted in any differences in cerebrospinal fluid markers indicative of cerebral ischaemia, All patients were anaesthetised with diazepam, fentanyl and pancuronium, after which ten patients received 50-60% nitrous oxide in oxygen until commencement of bypass, and the remaining patients 100% oxygen Because of the known effect of nitrous oxide in expanding gaseous bubbles, any neurological dysfunction of gaseous microembolic origin may be worsened in the presence of nitrous oxide, Patients were lumbar punctured 24 hours after cardiopulmonary bypass and cerebrospinal fluid analysed for thefollowing markers of central nervous system ischaemia: creatine kinase, lactate, total protein, noradrenaline, adrenaline and adenylate kinase, There was a statistically significant difference in cerebrospinal fluid lactate between the two groups, There were no statistically significant differences in the other cerebrospinal fluid markers of ischaemia,
gaseous microemboli in the production of these problems, 8 and the known ability of nitrous oxide to diffuse into and increase the size of air and oxygen spaces we examined whether the use of nitrous oxide in the prebypass period resulted in any differences in cerebrospinal fluid (CSF) markers indicative of cerebral ischaemia. We also intended to assess the reliability and feasibility of using these markers in larger studies looking at postbypass cerebral dysfunction.
MATERIALS AND METHODS Twenty patients who underwent elective coronary artery bypass grafting with an ejection fraction greater than 50% were studied ( Table 1) . This study has been approved by our Research and Ethics Committee and informed consent was obtained. Those patients who were over the age of 70 years, had known carotid or cerebrovascular disease, diabetes or concurrent valvular surgery were excluded. All surgery, including cannulation for CPB, was performed by the same surgeon (BB) and all perfusion supervised by the same medical perfusionist (HB). Although all concerned were aware the patient was being studied, no one, apart from the anaesthetist, was aware which group the patient was in. A Cobe Optiflo 11 bubble oxygenator was utilised with a 25 micron arterial inflow line micro-filter (Bentley). Cardiopulmonary bypass using haemodilution, hypothermia (25°C to 28°C) and cardioplegic arrest was used. Perfusion pressures while on bypass were maintained between 50 and 100 mmHg with flows of at least 2 litres/m2/min. Suction venting of the ascending aorta was used for ventricular decompression. Arterial blood gases were measured repeatedly, P02 was maintained in the range 150-300 mmHg, while Peo2 was kept at a temperature-corrected range of 35-45 mmHg. No patient had evidence of acid-base disturbance at the end of bypass, with the base excess in all patients within normal limits.
All patients were premedicated with omnopon 20 mg and scopolamine 0.4 mg IM, and received diazepam 5-10 mg IV during preoperative insertion of both radial artery and pulmonary artery catheters.
Anaesthesia was induced in all patients with further diazepam and fentanyl (10-15 uglkgl min) supplemented with pancuronium bromide and patients were then randomly allocated to one of two groups. Those patients in group 1 received in addition 50-66% nitrous oxide in oxygen until the commencement of cardiopulmonary bypass. After bypass they received 100% oxygen.
Patients in group 2 received 100% oxygen only at all times before and after bypass.
Heparin was administered to maintain the activated clotting time at greater than 400 seconds at all times while on bypass. No barbiturates were given to any patient included in this study. Twenty-four hours after bypass, patients were lumbar punctured in the intensive care unit using a 25-gauge needle. Three millilitres of CSF was withdrawn in each case. The CSF was immediately centrifuged to remove any cells. Aliquots were taken and frozen at minus 20°C. Subsequent biochemical analysis was performed for adenylate kinase, lactate, total proteins, creatine kinase, noradrenaline and adrenaline. Neurophysical assessment was limited to recognition (or not) by the patient of the anaesthetist who had obtained consent 48 hours previously, orientation in time, place and person, examination of cranial nerves and the peripheral nervous system (motor and sensory). Consent, lumbar puncture and assessment was carried out by an anaesthetist not involved in the intraoperative anaesthesia.
Adenylate kinase has been suggested as being a sensitive and reliable marker of neurological damage in the post-bypass period,9 having good correlation with changes in indices of intellectual function. This enzyme catalyses the dismutation reaction of one molecule each of adenosine monophosphate (AMP) and adenosine triphosphate (A TP) to two molecules of adenosine diphosphate (ADP). We intended to assay for adenylate kinase using the method described by Ronquist et al. to in 1979. However, this method was not sufficiently sensitive. We then tried a more sensitive method described by Hische et al. 11 but found again that we could not discriminate the enzyme catalysed reaction from the slow spontaneous reaction AMP + ATP~2 ADP.
On further inspection we found that their normal activity of 0.57 V/litre represented an absorbance change 'Of 0.0022 which is not discernible by the spectrophotometer. As no real method of increasing the activity of this enzyme has been described, we were not able to measure it in our patients.
Statistical correlation was made between P<0.9 P<0.05 P<0.13 P<0.9 P<0.5 7 (9) nitrous oxide versus non-nitrous oxide patients regarding CSF markers using the non parametric Mann-Whitney U test.
RESULTS
No focal neurologic deficits were manifested by any patients within the first 72 hours of bypass, One patient (Group 1) exhibited confusion and memory impairment for 36 hours post bypass. There was no mortality in either group and at discharge from hospital no patients had symptoms of cerebral dysfunction. The results are summarised in Table 2 .
DISCUSSION
Neurological complications of heart surgery have been recognised since the early description by Fox et al. 12 in 1954. The extracorporeal circulation has been implicated as a source of neurological morbidity in many subsequent studies. 2 ,6,7 Emboli of air, silicone, fat, platelet aggregates and fibrin, as well as vasoactive substances released from blood cell aggregates, have been claimed to be causes of central nervous system dysfunction after bypass. 13 The existence of gaseous microemboli was demonstrated more than a decade ago by Simmons et al. 14 system damage following cardiopulmonary bypass. Animal studies show that the level of CSF creatine phosphokinase can be reduced if an arterial inflow filter is used during bypass, supporting a microembolic role in the production of postoperative CNS dysfunction. 16 There was, however, no significant difference between our two groups.
The lactate concentration in CSF has been claimed to be increased in any condition with enhanced brain anaerobic glycolysis, such as cerebral ischaemia or infarction,17 and higher values of lactate in CSF correlate with a poor prognosis in patients with cerebral ischaemia. 18 Its reliability is enhanced as lactate is highly ionised and so does not cross the blood-brain barrier. There was a statistically significant difference in lactate levels between the two groups with the higher levels in the nitrous oxide group. Four patients in the nitrous oxide group had levels above the upper limit of normal for CSF lactate (2.3 mmol/litre). The patient who suffered confusion postoperatively had the highest CSF lactate level of 2.9 mmol/litre.
There was no statistically significant difference in our two groups with regard to CSF proteins. However, these levels were above normal (0.4 gmllitre) in the nitrous oxide group, perhaps suggesting blood-brain barrier disruption although we have no other specific confirmation of such disruption.
Elevated levels of catecholamines, particularly noradrenaline in lumbar CSF, have previously been reported in association with cerebral infarction I 9 and ischaemia associated with vasopasm. 20 This increase in CSF noradrenaline is thought to be a result of release from various brain sources in response to ischaemia, rather than being a primary cause of constriction of cerebral vessels. 20 Although CSF catecholamine levels have not been previously reported in the post-bypass period, the levels which we obtained are similar to those in normal subjects 2l and there was no statistically significant difference between either of our two groups.
We were disappointed that the enzyme adenylate kinase could not be satisfactorily assayed. This enzyme is of intracellular cytoplasmic origin within the CNS and is not normally detectable in the normal CSF. Its presence in CSF has been previously reported as an indicator of small and probably reversible ischaemic changes in brain tissue. lo As such it held great promise as a quantifiable index of ischaemia following cardiopulmonary bypass, but the inherent problems with the assaying technique led us to conclude that it is unreliable as a marker of cerebral ischaemia.
Gaseous microemboli are introduced to the open-heart surgical patient from several sources. Cannulation of the ascending aorta inevitably introduces small bubbles. Gas which is trapped in open cardiac chambers may enter the circulation, but even in closed cardiac procedures, such as coronary artery bypass grafting, an 11 % incidence of systemic air embolisation has been reported. 22 This air may come from retrograde aspiration of open coronary arteries, especially when suctioning venting of the ascending aorta is used for ventricular decompression. Suctioning of blood via the cardiotomy by definition returns air to the oxygenator, and air may be transmitted to the patient. The bubble oxygenator, which has a direct blood gas interface, releases higher counts of gaseous microemboli than do membrane oxygenators. 8 Nevertheless, all contemporary bypass circuits are capable of releasing gaseous microemboli. Cavitation bubbles may occur at turbulent regions in the circuit or following rewarming. The use of arterial line filters reduces the incidence of gaseous microemboli significantly8 but mechanical disturbance or agitation of the oxygenator or arterial line filter can lead to showers of these emboli. Other potential sources of gaseous microemboli include the injection of drugs into the patient's intravenous lines or extracorporeal circuit and the infusion of cold cardioplegic solutions to the aortic root.
The use of nitrous oxide as an anaesthetic agent immediately prior to the institution of bypass has been implicated in the growth of gaseous microemboli as bubbles of different gas compositions equilibrate. Nitrous oxide is twenty times more soluble than oxygen and around thirty times more soluble than nitrogen. Therefore bubbles will grow to an extent dependent on the partial pressure of nitrous oxide in the patient's arterial blood. Although this change in volume is well documented 23 in large closed spaces such as pneumothoraces, the effect on smaller bubbles is less clear. However, Munson and Merrick 24 found that 75% nitrous oxide decreased the volume of intravenous air needed to cause death in rabbits by 3.4 times -almost exactly proportional to the increase in gas volume that could be produced by diffusion of nitrous oxide into the air bubbles. It was because of the fact that the highest counts of gaseous microemboli occur immediately upon the commencement of bypass 8 that Bethune 25 recommended the discontinuation of nitrous oxide at least 10 minutes prior to the initiation of bypass, so that the alveolar concentration of nitrous oxide would in most instances be less than 10%.
The use of nitrous oxide and its role in contemporary open-heart surgery is under question because of its potentially deleterious effects on myocardium and systemic and pulmonary circulations. 26 Our study was designed to test the hypothesis that the use of nitrous oxide in the pre-bypass period would worsen any contributing role of gaseous microemboli in the production of neurological dysfunction. With our methods of perfusion and surgery we were able to suggest that the use of nitrous oxide does result in a statistically significant difference in CSF lactate. The levels of CSF lactate in this nitrous oxide group are equivalent to the levels described by Aberg 9 in relation to patients with neurological damage. Therefore, in view of the theoretical considerations of the effect of nitrous oxide on gaseous microemboli, the recommendation to Anaesthesia and Intensi,'e Care, Vo!. 15 , No. 4, NOI'ember, 1987 discontinue its use 10 minutes prior to the onset of cardiopulmonary bypass would seem reasonable.
